Cancer News Network

Cancer Awareness , Developments in Cancer Research and News on Cancer

Thursday, December 14, 2006

New therapies are changing the outlook for blood cancer patients


Medical News Today: The International Myeloma Foundation (IMF) - conducting research and providing education, advocacy and support for myeloma patients, families, researchers and physicians - noted that multiple studies presented at the 2006 Annual Meeting of the American Society of Hematology (ASH) illustrate the breadth of the gains being made in the treatment of multiple myeloma and related blood cancers.

The findings show that new treatment regimens that began with THALOMID® and extend to both VELCADE® and the newest oral treatment REVLIMID® are helping a growing range of myeloma patients when used alone, sequentially and in various combinations. Collectively, these studies represent a significant increase in knowledge of how myeloma responds to treatment, which is already becoming applicable to other cancers.

The patient groups studied cover the full range, from relapsed patients to the newly diagnosed, young to old, and include patients with an otherwise poor prognosis due to chromosomal abnormalities. In some cases the data being presented at the conference significantly advances previous studies to show long-term response in newly diagnosed patients. In one of the most significant studies, researchers from the Mayo Clinic report 67% of patients using REVLIMID (plus the steroid dexamethasone) as primary therapy, achieved a response categorized as complete or very good, with a low rate of disease progression continuing even after two years.

Read more this story…

Labels: , , , ,

1 Comments:

Anonymous ado said...

Blood Cancer


Blood cancer is a generalized term for malignancy which attacks the blood, bone marrow, or lymphatic system। There are three kinds of blood cancer: leukemia, lymphoma, and multiple myeloma.

Leukemia is malignancy of cells in the blood। Lymphoma refers to malignant tumors of the lymph system. Myeloma is malignancy of plasma cells. Plasma cells are the cells in bone marrow that produce antibodies. Collectively they are called Hematological malignancies.


Source

http://medicines5.blogspot.com/2010/05/blood-cancer.html

10:29 AM  

Post a Comment

Links to this post:

Create a Link

<< Home